Editorials Sep 4, 2014

Novartis drug probe falls short

The Tokyo criminal probe into the manipulation of clinical data pertaining to the efficacy of a Novartis Pharma-marketed drug for blood pressure has failed to unravel the whole picture of the scandal.

National Jul 29, 2013

Health ministry probes Diovan skin disruption reports

The health ministry is investigating reports of skin problems linked to the use of Diovan, Novartis Pharma K.K.'s popular drug for reducing high blood pressure, sources familiar with the matter said Monday. After probing reports that skin sores occur after taking the drug, the Health, ...

Data in Novartis drug study manipulated

National Jul 12, 2013

Data in Novartis drug study manipulated

The data used in a clinical study on Novartis Pharma K.K.'s blockbuster blood pressure drug Diovan were manipulated, Kyoto Prefectural University of Medicine has revealed. The research, based on around 3,000 Japanese with high blood pressure, was started in 2004 by Hiroaki Matsubara, a former ...